Skip to main content

Using Telehealth to Care for Incarcerated Populations with HIV

AAHIVM Course Banner
1.0 CEUs
Using Telehealth to Care for Incarcerated Populations with HIV

Module Description  Each year, the American Academy of HIV Medicine, supported by the Institute for Technology in Healthcare awards the Cesar Augusto Cacares Award for Technology in HIV Practice. Established in 2010, this award was designed to highlight innovative HIV programs and best practices that incorporate the use of technology to facilitate HIV care. The 2022 award was jointly awarded to the Madison Clinic at Harborview Health and the King County Department of Corrections for their innovative use of telehealth to facilitate the diagnosis of HIV, initiation of treatment, and linkage to care for incarcerated populations in King County, Washington.

Credit Dates 01/01/2023 – 12/31/2023

Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine.

This activity is supported by an independent educational grant from the Institute for Technology in Healthcare.

Learning Objectives
  • Describe barriers to care for people with HIV affected by incarceration and the need for innovative models of care
  • Define the components of a successful telemedicine program for incarcerated populations with HIV
  • Identify the importance of multidisciplinary collaboration between community and correctional health partners to improve HIV care
  • Discuss how telehealth can facilitate HIV diagnosis, initiation of treatment, and linkage to care for people with HIV in jails

Target Audience
This activity is intended for physicians, PAs, NPs, RNs, and pharmacists who are engaged in the care of people with HIV.

Estimated Time to Complete the Activity: 1 hour

Dr. Hillary Liss, MD, AAHIVS
Associate Professor, General Internal Medicine
University of Washington School of Medicine
Seattle, WA

Dr. Jennifer Jones-Vanderleest, MD, MSPH, AAHIVS
Clinical Associate Professor of Health Systems and Population Health
University of Washington School of Public Health
Seattle, WA

Method of Participation and Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity.

During the period January 1, 2023 through December 31, 2023, participants must read the learning objectives and faculty disclosures and study the educational activity.

In order to obtain your CE credit, please follow the steps below at the conclusion of the activity:

  1. Visit
  2. Enter your profile information
  3. (If applicable) Complete the post-test with a passing score of 75% or better
  4. Complete the activity evaluation
  5. Upon successfully completing the post-test (if applicable) and activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test (if applicable) with a score of 75% or better and the online evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.

If you have questions regarding the certification of this activity, please contact PACE by visiting ttps://

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education PACE designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008073-9999-22-303-H02-P)
Type of Activity: Knowledge

Continuing Nursing Education The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hours.

Disclosure of Conflict of Interest
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Dr. Liss has nothing to disclose
Dr. Jones-Vanderleest has nothing to disclose
Planners and Managers
The PIM planners and managers have nothing to disclose.
The Academy managers have nothing to disclose.

Media: Internet

Computer System Requirements
This program requires the use of an internet-connected computer or device and a modern web browser capable of streaming video.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.